← FDA DRUG APPROVALS

FDA ANDA · ANDA084386

DIGOXIN

Sponsor: WYETH AYERST

APPLICATION
ANDA084386
TYPE
ANDA
ORIGINAL APPROVAL
1976-07-12
LATEST ACTION
1998-08-25
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

DIGOXINDiscontinued
DIGOXIN 0.25MG/ML · INJECTABLE · INJECTION

Approval history

1998-08-25Labeling · Supplement 12AP
1993-03-10Labeling · Supplement 11AP
1991-02-15Labeling · Supplement 9AP
1987-03-12Manufacturing (CMC) · Supplement 6AP
1984-11-30Manufacturing (CMC) · Supplement 4AP
1976-07-12OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →